The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care prices, quality, access and innovation. “States have enacted COPAs with the assumption that regulatory oversight can mitigate the effects of lost competition and may allow hospitals to achieve certain efficiencies,” FTC said. “The Commission is interested in empirical research on the actual benefits and harms associated with COPAs, and on qualitative analyses of stakeholders’ experience with COPAs. Such studies and analyses, as well as the information presented at this workshop, may help advance the agency’s policy and enforcement strategies.” The workshop is part of FTC’s COPA Assessment Project.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Nov. 25 announced lower prices for 15 Medicare Part D drugs selected for the second cycle of negotiations…
Headline
The Advanced Research Projects Agency for Health announced Nov. 21 that it will fund up to $100 million in projects for quantitative measures of mental and…
Headline
Dan Peterson, CEO of behavioral health services at Sutter Health, and Matthew White, M.D., chair of the behavioral health service line at Sutter Health, share…
Headline
The Centers for Medicare & Medicaid Services released a bulletin Nov. 18 summarizing provisions from the budget reconciliation bill related to Medicaid and…
Headline
The Department of Homeland Security Nov. 17 published a proposed rule regarding “Public Charge Ground of Inadmissibility.” DHS proposed to…
Headline
The AHA and the Federation of American Hospitals Nov. 18 released a study conducted by Dobson | DaVanzo, underscoring the threat to patient care…